{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:52:55Z","timestamp":1794505975808,"version":"4.9.1"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019475","name":"Sidra Medicine","doi-asserted-by":"crossref","award":["SDR#400149"],"award-info":[{"award-number":["SDR#400149"]}],"id":[{"id":"10.13039\/100019475","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 1 diabetes affects millions of people globally and requires careful management to avoid serious long-term complications, including heart and kidney disease, stroke, and loss of sight. The type 1 diabetes patient cohort is highly heterogeneous, with individuals presenting with disease at different stages and severities, arising from distinct etiologies, and overlaying varied genetic backgrounds. At present, the \u201cone-size-fits-all\u201d treatment for type 1 diabetes is exogenic insulin substitution therapy, but this approach fails to achieve optimal blood glucose control in many individuals. With advances in our understanding of early-stage diabetes development, diabetes stratification, and the role of genetics, type 1 diabetes is a promising candidate for a personalized medicine approach, which aims to apply \u201cthe right therapy at the right time, to the right patient\u201d. In the case of type 1 diabetes, great efforts are now being focused on risk stratification for diabetes development to enable pre-clinical detection, and the application of treatments such as gene therapy, to prevent pancreatic destruction in a sub-set of patients. Alongside this, breakthroughs in stem cell therapies hold great promise for the regeneration of pancreatic tissues in some individuals. Here we review the recent initiatives in the field of personalized medicine for type 1 diabetes, including the latest discoveries in stem cell and gene therapy for the disease, and current obstacles that must be overcome before the dream of personalized medicine for all type 1 diabetes patients can be realized.<\/jats:p>","DOI":"10.1186\/s12967-021-02778-6","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T16:03:07Z","timestamp":1617292987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-070X","authenticated-orcid":false,"given":"Ammira Al-Shabeeb","family":"Akil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljazi","family":"Al-Maraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elbay","family":"Aliyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khulod","family":"Al-Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Fakhro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"issue":"6","key":"2778_CR1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.pcl.2005.07.006","volume":"52","author":"MJ Haller","year":"2005","unstructured":"Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatr Clin North Am. 2005;52(6):1553\u201378.","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"2778_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","volume":"62","author":"CC Patterson","year":"2019","unstructured":"Patterson CC, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989\u20132013: a multicentre prospective registration study. Diabetologia. 2019;62(3):408\u201317.","journal-title":"Diabetologia"},{"issue":"12","key":"2778_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s001250051309","volume":"42","author":"P Onkamo","year":"1999","unstructured":"Onkamo P, V\u00e4\u00e4n\u00e4nen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes\u2013the analysis of the data on published incidence trends. Diabetologia. 1999;42(12):1395\u2013403.","journal-title":"Diabetologia"},{"issue":"10","key":"2778_CR4","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2337\/diacare.23.10.1516","volume":"23","author":"M Karvonen","year":"2000","unstructured":"Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000;23(10):1516.","journal-title":"Diabetes Care"},{"key":"2778_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:48.","journal-title":"Diabetes Res Clin Pract"},{"issue":"26","key":"2778_CR6","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1056\/NEJMc0805398","volume":"359","author":"MJ Redondo","year":"2008","unstructured":"Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med. 2008;359(26):2849\u201350.","journal-title":"N Engl J Med"},{"issue":"10035","key":"2778_CR7","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","volume":"387","author":"F Pociot","year":"2016","unstructured":"Pociot F, Lernmark \u00c5. Genetic risk factors for type 1 diabetes. Lancet. 2016;387(10035):2331\u20139.","journal-title":"Lancet"},{"issue":"6","key":"2778_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.381","volume":"41","author":"JC Barrett","year":"2009","unstructured":"Barrett JC, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41(6):703\u20137.","journal-title":"Nat Genet"},{"issue":"2","key":"2778_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2337\/dc18-1785","volume":"42","author":"SA Sharp","year":"2019","unstructured":"Sharp SA, et al. Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diabetes Care. 2019;42(2):200.","journal-title":"Diabetes Care"},{"issue":"1","key":"2778_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajhg.2011.11.029","volume":"90","author":"PM Visscher","year":"2012","unstructured":"Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet. 2012;90(1):7\u201324.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"2778_CR11","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.2337\/diabetes.54.8.2482","volume":"54","author":"AK Steck","year":"2005","unstructured":"Steck AK, et al. Association of Non-HLA Genes With Type 1 Diabetes Autoimmunity. Diabetes. 2005;54(8):2482.","journal-title":"Diabetes"},{"issue":"7","key":"2778_CR12","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/hmg\/5.7.1075","volume":"5","author":"L Nistic\u00f2","year":"1996","unstructured":"Nistic\u00f2 L, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet. 1996;5(7):1075\u201380.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2778_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","volume":"18","author":"N Bottini","year":"2006","unstructured":"Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol. 2006;18(4):207\u201313.","journal-title":"Semin Immunol"},{"issue":"2","key":"2778_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1373\/clinchem.2010.148221","volume":"57","author":"AK Steck","year":"2011","unstructured":"Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 2011;57(2):176\u201385.","journal-title":"Clin Chem"},{"issue":"7","key":"2778_CR15","doi-asserted-by":"publisher","first-page":"e1000540","DOI":"10.1371\/journal.pgen.1000540","volume":"5","author":"DG Clayton","year":"2009","unstructured":"Clayton DG. Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet. 2009;5(7):e1000540.","journal-title":"PLoS Genet"},{"issue":"2","key":"2778_CR16","doi-asserted-by":"publisher","first-page":"e1000864","DOI":"10.1371\/journal.pgen.1000864","volume":"6","author":"NR Wray","year":"2010","unstructured":"Wray NR, Yang J, Goddard ME, Visscher PM. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet. 2010;6(2):e1000864.","journal-title":"PLoS Genet"},{"issue":"10","key":"2778_CR17","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.2337\/db13-0300","volume":"62","author":"J Ilonen","year":"2013","unstructured":"Ilonen J, Hammais A, Laine AP, Lempainen J, Vaarala O, Veijola R, Simell O, Knip M. Patterns of \u03b2-cell autoantibody appearance and genetic associations during the first years of life. Diabetes. 2013;62(10):3636\u201340.","journal-title":"Diabetes"},{"issue":"5","key":"2778_CR18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"Krischer JP, et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia. 2015;58(5):980\u20137.","journal-title":"Diabetologia"},{"issue":"13","key":"2778_CR19","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1001\/jama.290.13.1713","volume":"290","author":"JM Norris","year":"2003","unstructured":"Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, Rewers M. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA. 2003;290(13):1713\u201320.","journal-title":"JAMA"},{"issue":"6","key":"2778_CR20","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1007\/s00125-015-3555-2","volume":"58","author":"M Nygren","year":"2015","unstructured":"Nygren M, Carstensen J, Koch F, Ludvigsson J, Frostell A. Experience of a serious life event increases the risk for childhood type 1 diabetes: the ABIS population-based prospective cohort study. Diabetologia. 2015;58(6):1188\u201397.","journal-title":"Diabetologia"},{"issue":"10035","key":"2778_CR21","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/S0140-6736(16)30507-4","volume":"387","author":"M Rewers","year":"2016","unstructured":"Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet (London, England). 2016;387(10035):2340\u20138.","journal-title":"Lancet (London, England)"},{"issue":"7","key":"2778_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jama.2017.9730","volume":"318","author":"MM Leonard","year":"2017","unstructured":"Leonard MM, Sapone A, Catassi C, Fasano A. Celiac disease and nonceliac gluten sensitivity: a review. JAMA. 2017;318(7):647\u201356.","journal-title":"JAMA"},{"issue":"2","key":"2778_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11154-016-9403-y","volume":"18","author":"M Grammatiki","year":"2017","unstructured":"Grammatiki M, Rapti E, Karras S, Ajjan R, Kotsa K. Vitamin D and diabetes mellitus: Causal or casual association? Rev Endocr Metab Disord. 2017;18(2):227\u201341.","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2778_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrendo.2015.218","volume":"12","author":"M Knip","year":"2016","unstructured":"Knip M, Siljander H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol. 2016;12(3):154.","journal-title":"Nat Rev Endocrinol"},{"issue":"14","key":"2778_CR25","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJMoa032665","volume":"350","author":"A Hviid","year":"2004","unstructured":"Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Childhood vaccination and type 1 diabetes. N Engl J Med. 2004;350(14):1398\u2013404.","journal-title":"N Engl J Med"},{"issue":"6","key":"2778_CR26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jcjd.2016.05.002","volume":"40","author":"S Butalia","year":"2016","unstructured":"Butalia S, Kaplan GG, Khokhar B, Rabi DM. Environmental risk factors and type 1 diabetes: past, present, and future. Canad J Diabetes. 2016;40(6):586\u201393.","journal-title":"Canad J Diabetes"},{"issue":"7","key":"2778_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/BF00417700","volume":"37","author":"H Kolb","year":"1994","unstructured":"Kolb H, Elliott R. Increasing incidence of IDDM a consequence of improved hygiene? Diabetologia. 1994;37(7):729\u2013729.","journal-title":"Diabetologia"},{"issue":"1","key":"2778_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2008.03.003","volume":"31","author":"EE Baschal","year":"2008","unstructured":"Baschal EE, Eisenbarth GS. Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun. 2008;31(1):1\u20136.","journal-title":"J Autoimmun"},{"issue":"2","key":"2778_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12016-016-8592-1","volume":"52","author":"Z Wang","year":"2017","unstructured":"Wang Z, Xie Z, Lu Q, Chang C, Zhou Z. Beyond genetics: what causes type 1 diabetes. Clin Rev Allergy Immunol. 2017;52(2):273\u201386.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"2778_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/bmb\/ldn045","volume":"88","author":"KL Mehers","year":"2008","unstructured":"Mehers KL, Gillespie KM. The genetic basis for type 1 diabetes. Br Med Bull. 2008;88(1):115\u201329.","journal-title":"Br Med Bull"},{"issue":"10","key":"2778_CR31","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00125-019-4942-x","volume":"62","author":"ME Craig","year":"2019","unstructured":"Craig ME, Kim KW, Isaacs SR, Penno MA, Hamilton-Williams EE, Couper JJ, Rawlinson WD. Early-life factors contributing to type 1 diabetes. Diabetologia. 2019;62(10):1823\u201334.","journal-title":"Diabetologia"},{"issue":"11","key":"2778_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","volume":"15","author":"J Ilonen","year":"2019","unstructured":"Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2019;15(11):635\u201350.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"2778_CR33","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/jamainternmed.2020.1308","volume":"180","author":"K-P Chua","year":"2020","unstructured":"Chua K-P, Lee JM, Conti RM. Out-of-pocket spending for insulin, diabetes-related supplies, and other health care services among privately insured US patients with type 1 diabetes. JAMA Internal Med. 2020;180(7):1012\u20134.","journal-title":"JAMA Internal Med"},{"issue":"5","key":"2778_CR34","doi-asserted-by":"publisher","first-page":"e033231","DOI":"10.1136\/bmjopen-2019-033231","volume":"10","author":"M Stedman","year":"2020","unstructured":"Stedman M, et al. Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation. BMJ Open. 2020;10(5):e033231.","journal-title":"BMJ Open"},{"issue":"7","key":"2778_CR35","doi-asserted-by":"publisher","first-page":"e11501","DOI":"10.1371\/journal.pone.0011501","volume":"5","author":"B Tao","year":"2010","unstructured":"Tao B, Pietropaolo M, Atkinson M, Schatz D, Taylor D. Estimating the cost of type 1 diabetes in the US: a propensity score matching method. PloS one. 2010;5(7):e11501\u2013e11501.","journal-title":"PloS one"},{"issue":"10","key":"2778_CR36","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964\u201374.","journal-title":"Diabetes Care"},{"issue":"23","key":"2778_CR37","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309(23):2473\u20139.","journal-title":"JAMA"},{"key":"2778_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000481131","volume":"2","author":"R Insel","year":"2017","unstructured":"Insel R, Dutta S, Hedrick J. Type 1 diabetes: disease stratification. Biomedicine Hub. 2017;2:1\u201316.","journal-title":"Biomedicine Hub"},{"issue":"2","key":"2778_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1651-2227.1977.tb07830.x","volume":"66","author":"J Ludvigsson","year":"1977","unstructured":"Ludvigsson J, Heding L, Larsson Y, Leander E. C-peptide in juvenile diabetics beyond the postinitial remission period relation to clinical manifestations at onset of diabetes remission and diabetic control. Acta P\u00e6diatrica. 1977;66(2):177\u201384.","journal-title":"Acta P\u00e6diatrica"},{"key":"2778_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7326\/0003-4819-128-7-199804010-00001","volume":"128","author":"Control, D. and C.T.R. Group","year":"1998","unstructured":"Control, D. and C.T.R. Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med. 1998;128:517\u201323.","journal-title":"Ann Intern Med."},{"issue":"3","key":"2778_CR41","doi-asserted-by":"publisher","first-page":"832","DOI":"10.2337\/diacare.26.3.832","volume":"26","author":"MW Steffes","year":"2003","unstructured":"Steffes MW, Sibley S, Jackson M, Thomas W. \u03b2-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care. 2003;26(3):832\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"2778_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jama.2014.16107","volume":"313","author":"TJ Orchard","year":"2015","unstructured":"Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, Backlund J-YC, Lachin JM. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015;313(1):45\u201353.","journal-title":"JAMA"},{"issue":"11","key":"2778_CR43","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.2337\/dc11-1026","volume":"34","author":"HE Larsson","year":"2011","unstructured":"Larsson HE, et al. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care. 2011;34(11):2347\u201352.","journal-title":"Diabetes Care"},{"issue":"6","key":"2778_CR44","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/diacare.27.6.1399","volume":"27","author":"JM Barker","year":"2004","unstructured":"Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care. 2004;27(6):1399\u2013404.","journal-title":"Diabetes Care"},{"issue":"4","key":"2778_CR45","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1542\/peds.2013-2795","volume":"133","author":"D Dabelea","year":"2014","unstructured":"Dabelea D, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938\u201345.","journal-title":"Pediatrics"},{"issue":"4","key":"2778_CR46","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1399-5448.2011.00829.x","volume":"13","author":"C Winkler","year":"2012","unstructured":"Winkler C, Schober E, Ziegler AG, Holl RW. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies. Pediatr Diabetes. 2012;13(4):308\u201313.","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"2778_CR47","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/pedi.12151","volume":"15","author":"M Lundgren","year":"2014","unstructured":"Lundgren M, et al. Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up. Pediatr Diabetes. 2014;15(7):494\u2013501.","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"2778_CR48","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00125-013-2960-7","volume":"56","author":"JP Krischer","year":"2013","unstructured":"Krischer JP. The use of intermediate endpoints in the design of type 1 diabetes prevention trials. Diabetologia. 2013;56(9):1919\u201324.","journal-title":"Diabetologia"},{"issue":"9789","key":"2778_CR49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","volume":"378","author":"T Orban","year":"2011","unstructured":"Orban T, et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):412\u20139.","journal-title":"Lancet"},{"issue":"8","key":"2778_CR50","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","volume":"26","author":"LA Ferrat","year":"2020","unstructured":"Ferrat LA, et al. A combined risk score enhances prediction of type 1 diabetes among susceptible children. Nat Med. 2020;26(8):1247\u201355.","journal-title":"Nat Med"},{"issue":"3","key":"2778_CR51","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2337\/dc07-1459","volume":"31","author":"JM Sosenko","year":"2008","unstructured":"Sosenko JM, et al. A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial-Type 1. Diabetes Care. 2008;31(3):528\u201333.","journal-title":"Diabetes Care"},{"issue":"S20","key":"2778_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/pedi.12192","volume":"15","author":"O Rubio-Cabezas","year":"2014","unstructured":"Rubio-Cabezas O, Hattersley AT, Nj\u00f8lstad PR, Mlynarski W, Ellard S, White N, Chi DV, Craig ME. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15(S20):47\u201364.","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"2778_CR53","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pmed.1002548","volume":"15","author":"E Bonifacio","year":"2018","unstructured":"Bonifacio E, et al. Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children. PLoS Med. 2018;15(4):e1002548.","journal-title":"PLoS Med"},{"issue":"9","key":"2778_CR54","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2337\/dc18-0087","volume":"41","author":"MJ Redondo","year":"2018","unstructured":"Redondo MJ, et al. A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Diabetes Care. 2018;41(9):1887\u201394.","journal-title":"Diabetes Care"},{"issue":"7","key":"2778_CR55","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.2337\/db15-1690","volume":"65","author":"KA Patel","year":"2016","unstructured":"Patel KA, Oram RA, Flanagan SE, De Franco E, Colclough K, Shepherd M, Ellard S, Weedon MN, Hattersley AT. Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes. Diabetes. 2016;65(7):2094\u20139.","journal-title":"Diabetes"},{"key":"2778_CR56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mce.2015.07.028","volume":"418","author":"RM Wilson","year":"2015","unstructured":"Wilson RM, Messaoudi I. The impact of maternal obesity during pregnancy on offspring immunity. Mol Cell Endocrinol. 2015;418:134\u201342.","journal-title":"Mol Cell Endocrinol"},{"key":"2778_CR57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fped.2017.00069","volume":"5","author":"B Arabin","year":"2017","unstructured":"Arabin B, Baschat AA. Pregnancy: An Underutilized Window Of Opportunity To Improve Long-Term Maternal And Infant Health\u2014An Appeal For Continuous Family Care And Interdisciplinary Communication. Front Pediat. 2017;5:69.","journal-title":"Front Pediat"},{"key":"2778_CR58","volume-title":"WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections","author":"WH Organization","year":"2018","unstructured":"Organization WH. WHO recommendations non-clinical interventions to reduce unnecessary caesarean sections. Berlin: World Health Organization; 2018."},{"key":"2778_CR59","doi-asserted-by":"publisher","first-page":"k3547","DOI":"10.1136\/bmj.k3547","volume":"362","author":"JC Antvorskov","year":"2018","unstructured":"Antvorskov JC, et al. Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark. BMJ (Clinical research ed). 2018;362:k3547\u2013k3547.","journal-title":"BMJ (Clinical research ed)"},{"issue":"12","key":"2778_CR60","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.2337\/diacare.26.12.3237","volume":"26","author":"CM Fronczak","year":"2003","unstructured":"Fronczak CM, Bar\u00f3n AE, Chase HP, Ross C, Brady HL, Hoffman M, Eisenbarth GS, Rewers M, Norris JM. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care. 2003;26(12):3237\u201342.","journal-title":"Diabetes Care"},{"issue":"1","key":"2778_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2431-13-124","volume":"13","author":"Penno, M.A.S., J.J. Couper, M.E. Craig, P.G. Colman, W.D. Rawlinson, A.M. Cotterill, T.W. Jones, L.C. Harrison, and E.S. Group","year":"2013","unstructured":"Penno, M.A.S., J.J. Couper, M.E. Craig, P.G. Colman, W.D. Rawlinson, A.M. Cotterill, T.W. Jones, L.C. Harrison, and E.S. Group. Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr. 2013;13(1):124.","journal-title":"BMC Pediatr"},{"issue":"9","key":"2778_CR62","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamapediatrics.2013.158","volume":"167","author":"A Beyerlein","year":"2013","unstructured":"Beyerlein A, Wehweck F, Ziegler AG, Pflueger M. Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study. JAMA Pediatr. 2013;167(9):800\u20137.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2778_CR63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2337\/dc08-0821","volume":"32","author":"JJ Couper","year":"2009","unstructured":"Couper JJ, Beresford S, Hirte C, Baghurst PA, Pollard A, Tait BD, Harrison LC, Colman PG. Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care. 2009;32(1):94\u20139.","journal-title":"Diabetes Care"},{"issue":"9","key":"2778_CR64","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/jamapediatrics.2013.317","volume":"167","author":"B Frederiksen","year":"2013","unstructured":"Frederiksen B, Kroehl M, Lamb MM, Seifert J, Barriga K, Eisenbarth GS, Rewers M, Norris JM. Infant exposures and development of type 1 diabetes mellitus: The Diabetes Autoimmunity Study in the Young (DAISY). JAMA Pediat. 2013;167(9):808\u201315.","journal-title":"JAMA Pediat"},{"issue":"1","key":"2778_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/pedi.12115","volume":"16","author":"MM Lamb","year":"2015","unstructured":"Lamb MM, Miller M, Seifert JA, Frederiksen B, Kroehl M, Rewers M, Norris JM. The effect of childhood cow\u2019s milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young. Pediatr Diabetes. 2015;16(1):31\u20138.","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"2778_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.autrev.2015.12.005","volume":"15","author":"B Porcelli","year":"2016","unstructured":"Porcelli B, Pozza A, Bizzaro N, Fagiolini A, Costantini MC, Terzuoli L, Ferretti F. Association between stressful life events and autoimmune diseases: a systematic review and meta-analysis of retrospective case-control studies. Autoimmun Rev. 2016;15(4):325\u201334.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"2778_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrendo.2010.27","volume":"6","author":"D Hober","year":"2010","unstructured":"Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol. 2010;6(5):279.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"2778_CR68","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1007\/s00125-009-1428-2","volume":"52","author":"MM Lamb","year":"2009","unstructured":"Lamb MM, Yin X, Zerbe GO, Klingensmith GJ, Dabelea D, Fingerlin TE, Rewers M, Norris JM. Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young. Diabetologia. 2009;52(10):2064\u201371.","journal-title":"Diabetologia"},{"issue":"6","key":"2778_CR69","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1210\/jc.2004-0276","volume":"89","author":"S Ten","year":"2004","unstructured":"Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89(6):2526\u201339.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2778_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/db13-0617","volume":"63","author":"H Peiris","year":"2014","unstructured":"Peiris H, Bonder CS, Coates PTH, Keating DJ, Jessup CF. The \u03b2-cell\/EC axis: how do islet cells talk to each other? Diabetes. 2014;63(1):3.","journal-title":"Diabetes"},{"issue":"5","key":"2778_CR71","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.chom.2015.04.010","volume":"17","author":"LA Yurkovetskiy","year":"2015","unstructured":"Yurkovetskiy LA, Pickard JM, Chervonsky AV. Microbiota and autoimmunity: exploring new avenues. Cell Host Microbe. 2015;17(5):548\u201352.","journal-title":"Cell Host Microbe"},{"key":"2778_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1447.062","volume":"1150","author":"Group, T.S.","year":"2008","unstructured":"Group, T.S. The environmental determinants of diabetes in the young (TEDDY) Study. Ann N Y Acad Sci. 2008;1150:1\u201313.","journal-title":"Ann N Y Acad Sci"},{"key":"2778_CR73","doi-asserted-by":"publisher","first-page":"148673","DOI":"10.1155\/2013\/148673","volume":"2013","author":"M Chakhtoura","year":"2013","unstructured":"Chakhtoura M, Azar ST. The role of vitamin D deficiency in the incidence, progression, and complications of type 1 diabetes mellitus. Int J Endocrinol. 2013;2013:148673.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2778_CR74","first-page":"7","volume":"90","author":"PF Pereira","year":"2014","unstructured":"Pereira PF, Alfenas R, Ara\u00fajo RMA. Does breastfeeding influence the risk of developing diabetes mellitus in children? A review of current evidence. J Pediat (English Edition). 2014;90(1):7\u201315.","journal-title":"J Pediat (English Edition)"},{"issue":"12","key":"2778_CR75","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/jama.298.12.1420","volume":"298","author":"JM Norris","year":"2007","unstructured":"Norris JM, et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA. 2007;298(12):1420\u20138.","journal-title":"JAMA"},{"issue":"1","key":"2778_CR76","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/jamapediatrics.2015.2757","volume":"170","author":"U Uusitalo","year":"2016","unstructured":"Uusitalo U, et al. Association of early exposure of probiotics and islet autoimmunity in the TEDDY Study. JAMA Pediatr. 2016;170(1):20\u20138.","journal-title":"JAMA Pediatr"},{"issue":"suppl 2","key":"2778_CR77","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.2337\/diabetes.54.suppl_2.S125","volume":"54","author":"M Knip","year":"2005","unstructured":"Knip M, Veijola R, Virtanen SM, Hy\u00f6ty H, Vaarala O, \u00c5kerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes. 2005;54(suppl 2):S125.","journal-title":"Diabetes"},{"issue":"9","key":"2778_CR78","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3390\/nu11092185","volume":"11","author":"M Infante","year":"2019","unstructured":"Infante M, et al. Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes. Nutrients. 2019;11(9):2185.","journal-title":"Nutrients"},{"issue":"9","key":"2778_CR79","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s00125-013-2929-6","volume":"56","author":"LC Stene","year":"2013","unstructured":"Stene LC, Gale EAM. The prenatal environment and type 1 diabetes. Diabetologia. 2013;56(9):1888\u201397.","journal-title":"Diabetologia"},{"issue":"3","key":"2778_CR80","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/dc15-1111","volume":"39","author":"RA Oram","year":"2016","unstructured":"Oram RA, Patel K, Hill A, Shields B, McDonald TJ, Jones A, Hattersley AT, Weedon MN. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care. 2016;39(3):337\u201344.","journal-title":"Diabetes Care"},{"issue":"2","key":"2778_CR81","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018;6(2):122\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2778_CR82","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00125-019-4863-8","volume":"62","author":"NJ Thomas","year":"2019","unstructured":"Thomas NJ, Lynam AL, Hill AV, Weedon MN, Shields BM, Oram RA, McDonald TJ, Hattersley AT, Jones AG. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes. Diabetologia. 2019;62(7):1167\u201372.","journal-title":"Diabetologia"},{"issue":"12","key":"2778_CR83","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s00125-020-05246-w","volume":"63","author":"PW Franks","year":"2020","unstructured":"Franks PW, Pomares-Millan H. Next-generation epidemiology: the role of high-resolution molecular phenotyping in diabetes research. Diabetologia. 2020;63(12):2521\u201332.","journal-title":"Diabetologia"},{"issue":"2","key":"2778_CR84","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/pedi.12066","volume":"15","author":"H Elding Larsson","year":"2014","unstructured":"Elding Larsson H, et al. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes. 2014;15(2):118\u201326.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"2778_CR85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/jcm5010005","volume":"5","author":"BH McAdams","year":"2016","unstructured":"McAdams BH, Rizvi AA. An overview of insulin pumps and glucose sensors for the generalist. J Clin Med. 2016;5(1):5.","journal-title":"J Clin Med"},{"issue":"4","key":"2778_CR86","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND Randomized Clinical Trial. JAMA. 2017;317(4):371\u20138.","journal-title":"JAMA"},{"issue":"5","key":"2778_CR87","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2337\/dc19-1459","volume":"43","author":"MI Maiorino","year":"2020","unstructured":"Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, Longo M, Giugliano D, Esposito K. Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146.","journal-title":"Diabetes Care"},{"issue":"8","key":"2778_CR88","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2337\/dci18-0002","volume":"41","author":"GE Umpierrez","year":"2018","unstructured":"Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579\u201389.","journal-title":"Diabetes Care"},{"key":"2778_CR89","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/pedi.12731","volume":"19","author":"JL Sherr","year":"2018","unstructured":"Sherr JL, Tauschmann M, Battelino T, de Bock M, Forlenza G, Roman R, Hood KK, Maahs DM. ISPAD clinical practice consensus guidelines 2018: diabetes technologies. Pediatr Diabetes. 2018;19:302\u201325.","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"2778_CR90","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/pedi.12711","volume":"19","author":"DJ DeSalvo","year":"2018","unstructured":"DeSalvo DJ, et al. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes. 2018;19(7):1271\u20135.","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"2778_CR91","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1210\/er.2018-00174","volume":"40","author":"RA Lal","year":"2019","unstructured":"Lal RA, Ekhlaspour L, Hood K, Buckingham B. Realizing a closed-loop (artificial pancreas) system for the treatment of type 1 diabetes. Endocr Rev. 2019;40(6):1521\u201346.","journal-title":"Endocr Rev"},{"issue":"3","key":"2778_CR92","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/dme.13816","volume":"36","author":"CK Boughton","year":"2019","unstructured":"Boughton CK, Hovorka R. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective? Diabet Med. 2019;36(3):279\u201386.","journal-title":"Diabet Med"},{"key":"2778_CR93","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/db18-964-P","volume":"67","author":"SB Choi","year":"2018","unstructured":"Choi SB, Hong ES, Noh YH. Open artificial pancreas system reduced hypoglycemia and improved glycemic control in patients with type 1 diabetes. Diabetes. 2018;67:964.","journal-title":"Diabetes"},{"issue":"9","key":"2778_CR94","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S2213-8587(16)00039-5","volume":"4","author":"CS Frandsen","year":"2016","unstructured":"Frandsen CS, Dejgaard TF, Madsbad S. Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus. Lancet Diabetes Endocrinol. 2016;4(9):766\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"2778_CR95","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2337\/dc16-0690","volume":"39","author":"B Ahr\u00e9n","year":"2016","unstructured":"Ahr\u00e9n B, et al. Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial. Diabetes Care. 2016;39(10):1693\u2013701.","journal-title":"Diabetes Care"},{"issue":"4","key":"2778_CR96","doi-asserted-by":"publisher","first-page":"e2983","DOI":"10.1002\/dmrr.2983","volume":"34","author":"H Meng","year":"2018","unstructured":"Meng H, Zhang A, Liang Y, Hao J, Zhang X, Lu J. Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials. Diabetes Metab Res Rev. 2018;34(4):e2983.","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"2778_CR97","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2147\/VHRM.S1978","volume":"4","author":"BJ Hoogwerf","year":"2008","unstructured":"Hoogwerf BJ, Doshi KB, Diab D. Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk. Vasc Health Risk Manag. 2008;4(2):355\u201362.","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"2778_CR98","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s13300-017-0282-3","volume":"8","author":"W Wang","year":"2017","unstructured":"Wang W, Liu H, Xiao S, Liu S, Li X, Yu P. Effects of insulin plus glucagon-like peptide-1 receptor agonists (GLP-1RAs) in treating type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetes Ther. 2017;8(4):727\u201338.","journal-title":"Diabetes Ther"},{"issue":"4","key":"2778_CR99","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409\u201339.","journal-title":"Physiol Rev"},{"key":"2778_CR100","doi-asserted-by":"publisher","first-page":"212283","DOI":"10.7573\/dic.212283","volume":"4","author":"L Prasad-Reddy","year":"2015","unstructured":"Prasad-Reddy L, Isaacs D. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context. 2015;4:212283\u2013212283.","journal-title":"Drugs Context"},{"issue":"3","key":"2778_CR101","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1177\/1932296817699847","volume":"11","author":"LJ Underland","year":"2017","unstructured":"Underland LJ, Ilkowitz JT, Katikaneni R, Dowd A, Heptulla RA. Use of sitagliptin with closed-loop technology to decrease postprandial blood glucose in type 1 diabetes. J Diabetes Sci Technol. 2017;11(3):602\u201310.","journal-title":"J Diabetes Sci Technol"},{"key":"2778_CR102","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.diabres.2016.08.022","volume":"121","author":"H Guo","year":"2016","unstructured":"Guo H, Fang C, Huang Y, Pei Y, Chen L, Hu J. The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2016;121:184\u201391.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2778_CR103","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1210\/er.2014-1035","volume":"35","author":"EE Mulvihill","year":"2014","unstructured":"Mulvihill EE, Drucker DJ. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr Rev. 2014;35(6):992\u20131019.","journal-title":"Endocr Rev"},{"key":"2778_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2018.04.018","volume":"133","author":"S Dellepiane","year":"2018","unstructured":"Dellepiane S, BenNasr M, Assi E, Usuelli V, Letizia T, Addio F, Zuccotti GV, Fiorina P. Sodium glucose cotransporters inhibitors in type 1 diabetes. Pharmacol Res. 2018;133:1\u20138.","journal-title":"Pharmacol Res"},{"issue":"6","key":"2778_CR105","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.clinthera.2015.03.004","volume":"37","author":"K Whalen","year":"2015","unstructured":"Whalen K, Miller S, Onge ES. the role of sodium-glucose co-transporter 2 inhibitors in the treatment of type 2 diabetes. Clin Ther. 2015;37(6):1150\u201366.","journal-title":"Clin Ther"},{"issue":"2","key":"2778_CR106","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13300-014-0089-4","volume":"5","author":"S Kalra","year":"2014","unstructured":"Kalra S. Sodium glucose co-transporter-2 (SGLT2) inhibitors: a review of their basic and clinical pharmacology. Diabetes Therapy. 2014;5(2):355\u201366.","journal-title":"Diabetes Therapy"},{"issue":"7","key":"2778_CR107","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s42255-020-0212-y","volume":"2","author":"NS Tyler","year":"2020","unstructured":"Tyler NS, et al. An artificial intelligence decision support system for the management of type 1 diabetes. Nat Metabol. 2020;2(7):612\u20139.","journal-title":"Nat Metabol"},{"issue":"6","key":"2778_CR108","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2337\/dc15-0078","volume":"38","author":"KM Miller","year":"2015","unstructured":"Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV. Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015;38(6):971\u20138.","journal-title":"Diabetes Care"},{"issue":"7","key":"2778_CR109","doi-asserted-by":"publisher","first-page":"e0217301","DOI":"10.1371\/journal.pone.0217301","volume":"14","author":"N Resalat","year":"2019","unstructured":"Resalat N, El Youssef J, Tyler N, Castle J, Jacobs PG. A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model. PLoS ONE. 2019;14(7):e0217301.","journal-title":"PLoS ONE"},{"key":"2778_CR110","doi-asserted-by":"crossref","unstructured":"Cover T, Hart p. Nearest Neighbor Pattern Classification (1967) journal= The Edison Foundation Institute for Electric Efficiency. The Edison Foundation Institute for Electric Efficiency, p. 21\u201327.","DOI":"10.1109\/TIT.1967.1053964"},{"issue":"6","key":"2778_CR111","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/9442","volume":"5","author":"MA Atkinson","year":"1999","unstructured":"Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: As good as it gets? Nat Med. 1999;5(6):601\u20134.","journal-title":"Nat Med"},{"issue":"11","key":"2778_CR112","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/emmm.201202287","volume":"5","author":"KB Kaufmann","year":"2013","unstructured":"Kaufmann KB, B\u00fcning H, Galy A, Schambach A, Grez M. Gene therapy on the move. EMBO Mol Med. 2013;5(11):1642\u201361.","journal-title":"EMBO Mol Med"},{"key":"2778_CR113","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.biopha.2018.09.138","volume":"108","author":"DK Chellappan","year":"2018","unstructured":"Chellappan DK, et al. Gene therapy and type 1 diabetes mellitus. Biomed Pharmacother. 2018;108:1188\u2013200.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2778_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1538\/expanim1978.29.1_1","volume":"29","author":"S Makino","year":"1980","unstructured":"Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Exp Anim. 1980;29(1):1\u201313.","journal-title":"Exp Anim"},{"issue":"4","key":"2778_CR115","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1538\/expanim1978.34.4_425","volume":"34","author":"S Makino","year":"1985","unstructured":"Makino S, Muraoka Y, Kishimoto Y, Hayashi Y. Genetic analysis for insulitis in NOD mice. Exp Anim. 1985;34(4):425\u201331.","journal-title":"Exp Anim"},{"issue":"9207","key":"2778_CR116","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0140-6736(99)07125-1","volume":"355","author":"Group, E.A.S.","year":"2000","unstructured":"Group, E.A.S. Variation and trends in incidence of childhood diabetes in Europe. Lancet. 2000;355(9207):873\u20136.","journal-title":"Lancet"},{"issue":"11","key":"2778_CR117","doi-asserted-by":"publisher","first-page":"7641","DOI":"10.1101\/cshperspect.a007641","volume":"2","author":"MA Atkinson","year":"2012","unstructured":"Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harbor perspectives in medicine. 2012;2(11):7641.","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"11","key":"2778_CR118","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.4049\/jimmunol.173.11.6603","volume":"173","author":"E Melanitou","year":"2004","unstructured":"Melanitou E, Devendra D, Liu E, Miao D, Eisenbarth GS. Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset. J Immunol. 2004;173(11):6603\u201310.","journal-title":"J Immunol"},{"issue":"5","key":"2778_CR119","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2337\/diabetes.54.5.1415","volume":"54","author":"S You","year":"2005","unstructured":"You S, et al. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes. 2005;54(5):1415\u201322.","journal-title":"Diabetes"},{"issue":"8","key":"2778_CR120","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.4049\/jimmunol.171.8.4040","volume":"171","author":"S Gregori","year":"2003","unstructured":"Gregori S, Giarratana N, Smiroldo S, Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol. 2003;171(8):4040\u20137.","journal-title":"J Immunol"},{"issue":"21","key":"2778_CR121","doi-asserted-by":"publisher","first-page":"12538","DOI":"10.1073\/pnas.95.21.12538","volume":"95","author":"TP DiLorenzo","year":"1998","unstructured":"DiLorenzo TP, Graser RT, Ono T, Christianson GJ, Chapman HD, Roopenian DC, Nathenson SG, Serreze DV. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor \u03b1 chain gene rearrangement. Proc Natl Acad Sci. 1998;95(21):12538\u201343.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"2778_CR122","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/db15-0779","volume":"65","author":"M Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson M, Fu A, Kaddis JS, Wasserfall C, Schatz DA, Pugliese A, Atkinson MA. Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes. Diabetes. 2016;65(3):719\u201331.","journal-title":"Diabetes"},{"issue":"5","key":"2778_CR123","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"P Leete","year":"2016","unstructured":"Leete P, Willcox A, Krogvold L, Dahl-J\u00f8rgensen K, Foulis AK, Richardson SJ, Morgan NG. Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes. Diabetes. 2016;65(5):1362\u20139.","journal-title":"Diabetes"},{"issue":"7","key":"2778_CR124","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.molmet.2017.05.007","volume":"6","author":"C Mallol","year":"2017","unstructured":"Mallol C, et al. AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice. Mol Metab. 2017;6(7):664\u201380.","journal-title":"Mol Metab"},{"issue":"1","key":"2778_CR125","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.gt.3301110","volume":"7","author":"S Li","year":"2000","unstructured":"Li S, Huang L. Nonviral gene therapy: promises and challenges. Gene Ther. 2000;7(1):31\u20134.","journal-title":"Gene Ther"},{"issue":"1","key":"2778_CR126","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1515\/bmc.2011.055","volume":"3","author":"A Parikh","year":"2012","unstructured":"Parikh A, Stephan A-F, Tzanakakis ES. Regenerating proteins and their expression, regulation, and signaling. Biomol Concepts. 2012;3(1):57\u201370.","journal-title":"Biomol Concepts"},{"issue":"4","key":"2778_CR127","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1006\/mthe.2001.0299","volume":"3","author":"R Chen","year":"2001","unstructured":"Chen R, Meseck ML, Woo SL. Auto-regulated hepatic insulin gene expression in type 1 diabetic rats. Mol Ther. 2001;3(4):584\u201390.","journal-title":"Mol Ther"},{"issue":"5498","key":"2778_CR128","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1126\/science.290.5498.1959","volume":"290","author":"AT Cheung","year":"2000","unstructured":"Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, Boylan MO, Wolfe MM, Kieffer TJ. Glucose-dependent insulin release from genetically engineered K cells. Science. 2000;290(5498):1959\u201362.","journal-title":"Science"},{"key":"2778_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2017.03.008","volume":"6","author":"ML Jaen","year":"2017","unstructured":"Jaen ML, et al. Long-term efficacy and safety of insulin and glucokinase gene therapy for diabetes: 8-year follow-up in dogs. Mol Ther Methods Clin Dev. 2017;6:1\u20137.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"2778_CR130","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/jcp.10139","volume":"192","author":"EB Ramshur","year":"2002","unstructured":"Ramshur EB, Rull TR, Wice BM. Novel insulin\/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo. J Cell Physiol. 2002;192(3):339\u201350.","journal-title":"J Cell Physiol"},{"issue":"9","key":"2778_CR131","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1007\/s00125-007-0722-0","volume":"50","author":"B Ren","year":"2007","unstructured":"Ren B, O\u2019Brien BA, Swan MA, Koina ME, Nassif N, Wei MQ, Simpson AM. Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia. 2007;50(9):1910\u201320.","journal-title":"Diabetologia"},{"issue":"8","key":"2778_CR132","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1365-2036.2010.04424.x","volume":"32","author":"Y Touchefeu","year":"2010","unstructured":"Touchefeu Y, Harrington KJ, Galmiche JP, Vassaux G. Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. Aliment Pharmacol Ther. 2010;32(8):953\u201368.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2778_CR133","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1002\/jgm.3067","volume":"21","author":"SU Gan","year":"2019","unstructured":"Gan SU, Fu Z, Sia KC, Kon OL, Calne R, Lee KO. Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetes. J Gene Med. 2019;21(1):3067.","journal-title":"J Gene Med"},{"issue":"12","key":"2778_CR134","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.2337\/db15-0066","volume":"64","author":"Y Lin","year":"2015","unstructured":"Lin Y, Sun Z. Antiaging Gene klotho attenuates pancreatic \u03b2-Cell apoptosis in type 1 diabetes. Diabetes. 2015;64(12):4298\u2013311.","journal-title":"Diabetes"},{"issue":"10","key":"2778_CR135","doi-asserted-by":"publisher","first-page":"E1308","DOI":"10.1210\/jc.2015-1800","volume":"100","author":"K Lim","year":"2015","unstructured":"Lim K, et al. \u03b1-Klotho expression in human tissues. J Clin Endocrinol Metab. 2015;100(10):E1308\u201318.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2778_CR136","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.bbrc.2017.10.029","volume":"493","author":"GJ Prud'homme","year":"2017","unstructured":"Prud\u2019homme GJ, Glinka Y, Kurt M, Liu W, Wang Q. The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells. Biochem Biophys Res Commun. 2017;493(4):1542\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2778_CR137","doi-asserted-by":"publisher","first-page":"696","DOI":"10.5603\/EP.a2018.0070","volume":"69","author":"J Floty\u0144ska","year":"2018","unstructured":"Floty\u0144ska J, Uruska A, Araszkiewicz A, Zozuli\u0144ska-Zi\u00f3\u0142kiewicz D. Klotho protein function among patients with type 1 diabetes. Endokrynol Pol. 2018;69(6):696\u2013704.","journal-title":"Endokrynol Pol"},{"issue":"4","key":"2778_CR138","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.dsx.2019.07.018","volume":"13","author":"AE Berezin","year":"2019","unstructured":"Berezin AE, Berezin AA. Impaired function of fibroblast growth factor 23 \/ Klotho protein axis in prediabetes and diabetes mellitus: promising predictor of cardiovascular risk. Diabetes Metabol Syndr. 2019;13(4):2549\u201356.","journal-title":"Diabetes Metabol Syndr"},{"issue":"10","key":"2778_CR139","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1210\/en.2016-1947","volume":"158","author":"A Xie","year":"2017","unstructured":"Xie A, et al. Anti-TCRbeta mAb in combination with neurogenin3 gene therapy reverses established overt type 1 diabetes in female NOD mice. Endocrinology. 2017;158(10):3140\u201351.","journal-title":"Endocrinology"},{"issue":"7","key":"2778_CR140","doi-asserted-by":"publisher","first-page":"159276","DOI":"10.1371\/journal.pone.0159276","volume":"11","author":"AR Cox","year":"2016","unstructured":"Cox AR, et al. Resolving discrepant findings on ANGPTL8 in \u03b2-cell proliferation: a collaborative approach to resolving the betatrophin controversy. PLoS ONE. 2016;11(7):159276.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"2778_CR141","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cell.2016.12.017","volume":"168","author":"P Yi","year":"2017","unstructured":"Yi P, Park J-S, Melton DA. Retraction notice to: betatrophin: A hormone that controls pancreatic \u03b2 cell proliferation. Cell. 2017;168(1\u20132):326.","journal-title":"Cell"},{"issue":"3","key":"2778_CR142","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cell.2014.09.027","volume":"159","author":"V Gusarova","year":"2014","unstructured":"Gusarova V, et al. ANGPTL8\/betatrophin does not control pancreatic beta cell expansion. Cell. 2014;159(3):691\u20136.","journal-title":"Cell"},{"issue":"7","key":"2778_CR143","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00125-015-3590-z","volume":"58","author":"AR Cox","year":"2015","unstructured":"Cox AR, Lam CJ, Bonnyman CW, Chavez J, Rios JS, Kushner JA. Angiopoietin-like protein 8 (ANGPTL8)\/betatrophin overexpression does not increase beta cell proliferation in mice. Diabetologia. 2015;58(7):1523\u201331.","journal-title":"Diabetologia"},{"issue":"5","key":"2778_CR144","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00125-015-3521-z","volume":"58","author":"J Chen","year":"2015","unstructured":"Chen J, Chen S, Huang P, Meng X-L, Clayton S, Shen J-S, Grayburn PA. In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats. Diabetologia. 2015;58(5):1036\u201344.","journal-title":"Diabetologia"},{"issue":"11","key":"2778_CR145","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/gt.2010.85","volume":"17","author":"S Chen","year":"2010","unstructured":"Chen S, Shimoda M, Wang M-Y, Ding J, Noguchi H, Matsumoto S, Grayburn PA. Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy. Gene Ther. 2010;17(11):1411\u201320.","journal-title":"Gene Ther"},{"issue":"1","key":"2778_CR146","doi-asserted-by":"publisher","first-page":"10074","DOI":"10.1038\/s41598-018-28423-9","volume":"8","author":"Y Chen","year":"2018","unstructured":"Chen Y, et al. CTLA-4 +49 G\/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function. Sci Rep. 2018;8(1):10074.","journal-title":"Sci Rep"},{"issue":"6939","key":"2778_CR147","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423(6939):506\u201311.","journal-title":"Nature"},{"issue":"2","key":"2778_CR148","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1089\/nat.2013.0449","volume":"24","author":"DV Mourich","year":"2014","unstructured":"Mourich DV, Oda SK, Schnell FJ, Crumley SL, Hauck LL, Moentenich CA, Marshall NB, Hinrichs DJ, Iversen PL. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice. Nucleic Acid Ther. 2014;24(2):114\u201326.","journal-title":"Nucleic Acid Ther"},{"key":"2778_CR149","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3389\/fgene.2019.00868","volume":"10","author":"A Shahryari","year":"2019","unstructured":"Shahryari A, Saghaeian Jazi M, Mohammadi S, Razavi Nikoo H, Nazari Z, Hosseini ES, Burtscher I, Mowla SJ, Lickert H. Development and clinical translation of approved gene therapy products for genetic disorders. Front Genetics. 2019;10:868.","journal-title":"Front Genetics"},{"key":"2778_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2014.10.007","volume":"82\u201383","author":"C Tran","year":"2015","unstructured":"Tran C, Damaser MS. Stem cells as drug delivery methods: application of stem cell secretome for regeneration. Adv Drug Deliv Rev. 2015;82\u201383:1\u201311.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2778_CR151","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1095\/biolreprod.104.033480","volume":"72","author":"JB Lee","year":"2005","unstructured":"Lee JB, Lee JE, Park JH, Kim SJ, Kim MK, Roh SI, Yoon HS. Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition1. Biol Reprod. 2005;72(1):42\u20139.","journal-title":"Biol Reprod"},{"issue":"4","key":"2778_CR152","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nbt1393","volume":"26","author":"E Kroon","year":"2008","unstructured":"Kroon E, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443\u201352.","journal-title":"Nat Biotechnol"},{"key":"2778_CR153","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania A, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol. 2014;32:1121.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2778_CR154","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2006.71","volume":"1","author":"IS Schroeder","year":"2006","unstructured":"Schroeder IS, Rolletschek A, Blyszczuk P, Kania G, Wobus AM. Differentiation of mouse embryonic stem cells to insulin-producing cells. Nat Protoc. 2006;1(2):495\u2013507.","journal-title":"Nat Protoc"},{"issue":"1","key":"2778_CR155","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jmcb\/mjp037","volume":"2","author":"J Cai","year":"2010","unstructured":"Cai J, Yu C, Liu Y, Chen S, Guo Y, Yong J, Lu W, Ding M, Deng H. Generation of homogeneous PDX1(+) pancreatic progenitors from human ES cell-derived endoderm cells. J Mol Cell Biol. 2010;2(1):50\u201360.","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"2778_CR156","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/db17-0120","volume":"67","author":"L Sui","year":"2018","unstructured":"Sui L, et al. beta-Cell replacement in mice using human type 1 diabetes nuclear transfer embryonic stem cells. Diabetes. 2018;67(1):26\u201335.","journal-title":"Diabetes"},{"issue":"3","key":"2778_CR157","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.stemcr.2019.01.012","volume":"12","author":"MMF Qadir","year":"2019","unstructured":"Qadir MMF, et al. A double fail-safe approach to prevent tumorigenesis and select pancreatic \u03b2 cells from human embryonic stem cells. Stem Cell Reports. 2019;12(3):611\u201323.","journal-title":"Stem Cell Reports"},{"key":"2778_CR158","first-page":"284","volume":"5","author":"AG Kotini","year":"2016","unstructured":"Kotini AG, de Stanchina E, Themeli M, Sadelain M, Papapetrou EP. Escape mutations, ganciclovir resistance, and teratoma formation in human iPSCs expressing an HSVtk suicide gene. Molecular Therapy. 2016;5:284.","journal-title":"Molecular Therapy"},{"issue":"5391","key":"2778_CR159","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145\u20137.","journal-title":"Science"},{"issue":"5858","key":"2778_CR160","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):7\u20131920.","journal-title":"Science"},{"issue":"5","key":"2778_CR161","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2337\/db16-1406","volume":"66","author":"JR Millman","year":"2017","unstructured":"Millman JR, Pagliuca FW. Autologous pluripotent stem cell-derived \u03b2-like cells for diabetes cellular therapy. Diabetes. 2017;66(5):1111.","journal-title":"Diabetes"},{"issue":"2","key":"2778_CR162","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","volume":"12","author":"L Velazco-Cruz","year":"2019","unstructured":"Velazco-Cruz L, Song J, Maxwell KG, Goedegebuure MM, Augsornworawat P, Hogrebe NJ, Millman JR. Acquisition of dynamic function in human stem cell-derived \u03b2 cells. Stem Cell Reports. 2019;12(2):351\u201365.","journal-title":"Stem Cell Reports"},{"issue":"14","key":"2778_CR163","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","volume":"297","author":"JC Voltarelli","year":"2007","unstructured":"Voltarelli JC, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2007;297(14):1568\u201376.","journal-title":"JAMA"},{"issue":"15","key":"2778_CR164","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.2009.470","volume":"301","author":"CE Couri","year":"2009","unstructured":"Couri CE, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2009;301(15):1573\u20139.","journal-title":"JAMA"},{"key":"2778_CR165","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fendo.2017.00331","volume":"8","author":"JG Penaforte-Saboia","year":"2017","unstructured":"Penaforte-Saboia JG, et al. Microvascular complications in type 1 diabetes: a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic stem-cell transplantation and conventional medical therapy. Front Endocrinol (Lausanne). 2017;8:331.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2778_CR166","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.visres.2017.06.016","volume":"139","author":"AD Bhatwadekar","year":"2017","unstructured":"Bhatwadekar AD, et al. Hematopoietic stem\/progenitor involvement in retinal microvascular repair during diabetes: Implications for bone marrow rejuvenation. Vision Res. 2017;139:211\u201320.","journal-title":"Vision Res"},{"issue":"1","key":"2778_CR167","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13287-017-0542-1","volume":"8","author":"L Ye","year":"2017","unstructured":"Ye L, Li L, Wan B, Yang M, Hong J, Gu W, Wang W, Ning G. Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res Therapy. 2017;8(1):90.","journal-title":"Stem Cell Res Therapy"},{"issue":"5","key":"2778_CR168","doi-asserted-by":"publisher","first-page":"651","DOI":"10.5966\/sctm.2015-0144","volume":"5","author":"H Xiang","year":"2016","unstructured":"Xiang H, et al. Residual \u03b2-cell function predicts clinical response after autologous hematopoietic stem cell transplantation. Stem Cells Transl Med. 2016;5(5):651\u20137.","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"2778_CR169","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/bmt.2015.294","volume":"51","author":"E Snarski","year":"2016","unstructured":"Snarski E, et al. Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations. Bone Marrow Transplant. 2016;51(3):398\u2013402.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2778_CR170","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/pr.2011.57","volume":"71","author":"T Daikeler","year":"2012","unstructured":"Daikeler T, Tichelli A, Passweg J. Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases. Pediatr Res. 2012;71(2):439\u201344.","journal-title":"Pediatr Res"},{"issue":"4","key":"2778_CR171","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"6","key":"2778_CR172","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1172\/JCI200316502","volume":"111","author":"A Ianus","year":"2003","unstructured":"Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Investig. 2003;111(6):843\u201350.","journal-title":"J Clin Investig"},{"issue":"5","key":"2778_CR173","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.diff.2009.01.001","volume":"77","author":"Q-P Xie","year":"2009","unstructured":"Xie Q-P, Huang H, Xu B, Dong X, Gao S-L, Zhang B, Wu Y-L. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. Differentiation. 2009;77(5):483\u201391.","journal-title":"Differentiation"},{"issue":"8","key":"2778_CR174","doi-asserted-by":"publisher","first-page":"42177","DOI":"10.1371\/journal.pone.0042177","volume":"7","author":"A Milanesi","year":"2012","unstructured":"Milanesi A, Lee J-W, Li Z, Da Sacco S, Villani V, Cervantes V, Perin L, Yu JS. \u03b2-Cell regeneration mediated by human bone marrow mesenchymal stem cells. PLoS ONE. 2012;7(8):42177.","journal-title":"PLoS ONE"},{"issue":"8","key":"2778_CR175","first-page":"541","volume":"50","author":"M Ghodsi","year":"2012","unstructured":"Ghodsi M, Heshmat R, Amoli M, Keshtkar AA, Arjmand B, Aghayan H, Hosseini P, Sharifi AM, Larijani B. The effect of fetal liver-derived cell suspension allotransplantation on patients with diabetes: first year of follow-up. Acta Med Iran. 2012;50(8):541\u20136.","journal-title":"Acta Med Iran"},{"issue":"6","key":"2778_CR176","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11626-019-00364-1","volume":"55","author":"J Zhang","year":"2019","unstructured":"Zhang J, Mao R, Wang X, Liu K, Geng Q, Yu Y, Li Y, Qi J. Targeted induction of bone marrow mesenchymal stem cells to have effectiveness on diabetic pancreatic restoration. Vitro Cell Dev Biol. 2019;55(6):453\u201361.","journal-title":"Vitro Cell Dev Biol"},{"issue":"5","key":"2778_CR177","first-page":"851","volume":"157","author":"Z Qu-Petersen","year":"2002","unstructured":"Qu-Petersen Z, et al. Identification of a novel population of muscle stem cells in mice. Potent Muscle Regener. 2002;157(5):851\u201364.","journal-title":"Potent Muscle Regener"},{"issue":"sup3","key":"2778_CR178","doi-asserted-by":"publisher","first-page":"S328","DOI":"10.1080\/21691401.2018.1492421","volume":"46","author":"KC Lan","year":"2018","unstructured":"Lan KC, Wang CC, Yen YP, Yang RS, Liu SH, Chan DC. Islet-like clusters derived from skeletal muscle-derived stem\/progenitor cells for autologous transplantation to control type 1 diabetes in mice. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S328-s335.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"2778_CR179","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/j.bjps.2009.10.028","volume":"63","author":"A Sterodimas","year":"2010","unstructured":"Sterodimas A, de Faria J, Nicaretta B, Pitanguy I. Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg. 2010;63(11):1886\u201392.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2778_CR180","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2018.02.008","volume":"654","author":"MG Amer","year":"2018","unstructured":"Amer MG, Embaby AS, Karam RA, Amer MG. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus. Gene. 2018;654:87\u201394.","journal-title":"Gene"},{"issue":"1","key":"2778_CR181","doi-asserted-by":"publisher","first-page":"10759","DOI":"10.1038\/s41598-019-47257-7","volume":"9","author":"T Ikemoto","year":"2019","unstructured":"Ikemoto T, Feng R, Iwahashi SI, Yamada S, Saito Y, Morine Y, Imura S, Matsuhisa M, Shimada M. In vitro and in vivo effects of insulin-producing cells generated by xeno-antigen free 3D culture with RCP piece. Sci Rep. 2019;9(1):10759.","journal-title":"Sci Rep"},{"issue":"1","key":"2778_CR182","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13287-019-1135-y","volume":"10","author":"Q Fang","year":"2019","unstructured":"Fang Q, Zhai M, Wu S, Hu X, Hua Z, Sun H, Guo J, Zhang W, Wang Z. Adipocyte-derived stem cell-based gene therapy upon adipogenic differentiation on microcarriers attenuates type 1 diabetes in mice. Stem Cell Res Ther. 2019;10(1):36.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"2778_CR183","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/sctm.17-0244","volume":"7","author":"C Dessels","year":"2018","unstructured":"Dessels C, Alessandrini M, Pepper MS. Factors influencing the umbilical cord blood stem cell industry: an evolving treatment landscape. Stem Cells Transl Med. 2018;7(9):643\u201350.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"2778_CR184","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.07.009","volume":"79","author":"Y-J Kim","year":"2011","unstructured":"Kim Y-J, Broxmeyer HE. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol. 2011;79(2):112\u201326.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2778_CR185","doi-asserted-by":"publisher","first-page":"6901286","DOI":"10.1155\/2016\/6901286","volume":"2016","author":"I Arutyunyan","year":"2016","unstructured":"Arutyunyan I, Elchaninov A, Makarov A, Fatkhudinov T. Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells Int. 2016;2016:6901286.","journal-title":"Stem Cells Int"},{"issue":"6","key":"2778_CR186","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3727\/096368911X612530","volume":"21","author":"KR Prabakar","year":"2012","unstructured":"Prabakar KR, Dom\u00ednguez-Bendala J, Molano RD, Pileggi A, Villate S, Ricordi C, Inverardi L. Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Cell Transplant. 2012;21(6):1321\u201339.","journal-title":"Cell Transplant"},{"issue":"1","key":"2778_CR187","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1371\/journal.pone.0004226","volume":"4","author":"Y Zhao","year":"2009","unstructured":"Zhao Y, Lin B, Darflinger R, Zhang Y, Holterman MJ, Skidgel RA. Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS ONE. 2009;4(1):4226.","journal-title":"PLoS ONE"},{"issue":"1","key":"2778_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-10-3","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, et al. Reversal of type 1 diabetes via islet \u03b2 cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med. 2012;10(1):1\u201311.","journal-title":"BMC Med"},{"issue":"1","key":"2778_CR189","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","volume":"39","author":"J Cai","year":"2016","unstructured":"Cai J, et al. Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion. Diabetes Care. 2016;39(1):149\u201357.","journal-title":"Diabetes Care"},{"issue":"6","key":"2778_CR190","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.exphem.2008.01.009","volume":"36","author":"MJ Haller","year":"2008","unstructured":"Haller MJ, Viener H-L, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol. 2008;36(6):710\u20135.","journal-title":"Exp Hematol"},{"issue":"7","key":"2778_CR191","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.bbmt.2013.04.011","volume":"19","author":"MJ Haller","year":"2013","unstructured":"Haller MJ, et al. Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes. Biol Blood Marrow Transplant. 2013;19(7):1126\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2778_CR192","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/pedi.12072","volume":"15","author":"EZ Giannopoulou","year":"2014","unstructured":"Giannopoulou EZ, et al. Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial. Pediatr Diabetes. 2014;15(2):100\u20139.","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"2778_CR193","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","volume":"181","author":"A Schneider","year":"2008","unstructured":"Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J Immunol. 2008;181(10):7350\u20135.","journal-title":"J Immunol"},{"issue":"7","key":"2778_CR194","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1634\/stemcells.2004-0013","volume":"22","author":"HS Wang","year":"2004","unstructured":"Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC. Mesenchymal stem cells in the Wharton\u2019s jelly of the human umbilical cord. Stem cells. 2004;22(7):1330\u20137.","journal-title":"Stem cells"},{"key":"2778_CR195","doi-asserted-by":"publisher","first-page":"430847","DOI":"10.1155\/2015\/430847","volume":"2015","author":"I Kalaszczynska","year":"2015","unstructured":"Kalaszczynska I, Ferdyn K. Wharton\u2019s Jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance. BioMed Res Int. 2015;2015:430847.","journal-title":"BioMed Res Int"},{"key":"2778_CR196","first-page":"89","volume":"5","author":"J Hu","year":"2012","unstructured":"Hu J, et al. Long term effects of the implantation of Wharton&rsquo;s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocrine J. 2012;5:89.","journal-title":"Endocrine J"},{"key":"2778_CR197","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/S2213-8587(16)30372-2","volume":"4","author":"L Li","year":"2016","unstructured":"Li L, Lu J, Shen S, Jia X, Zhu D. Wharton\u2019s jelly-derived mesenchymal stem cell therapy to improve \u03b2-cell function in patients with type 1 diabetes and ketoacidosis: a single-centre, single-group, open-label, phase 2 trial. Lancet Diabetes Endocrinol. 2016;4:S17.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2778_CR198","first-page":"4520","volume":"11","author":"PN Hong-Wu Wang","year":"2018","unstructured":"Hong-Wu Wang PN. Han-Hua Yang, Li-Chun Xie, Li-Min Lin, Xiu-Lan Lai, Tian-You Wang, Lian Ma, Partially repair damaged Islets of diabetic rat model via insulin-producing cells differentiated from human umbilical cord mesenchymal stem cells infusion. Int J Clin Exp Med. 2018;11(5):4520\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"2778_CR199","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3727\/096368914X683016","volume":"24","author":"P-J Tsai","year":"2015","unstructured":"Tsai P-J, et al. Undifferentiated Wharton\u2019s jelly mesenchymal stem cell transplantation induces insulin-producing cell differentiation and suppression of T-cell-mediated autoimmunity in nonobese diabetic mice. Cell Transplant. 2015;24(8):1555\u201370.","journal-title":"Cell Transplant"},{"issue":"2","key":"2778_CR200","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/2542-3975.235141","volume":"3","author":"P-O Carlsson","year":"2018","unstructured":"Carlsson P-O, Svahn M. Wharton\u2019s jelly derived allogeneic mesenchymal stromal cells for treatment of type 1 diabetes: Study protocol for a double-blinded, randomized, parallel, placebo-controlled trial. Clin Trials Degener Dis. 2018;3(2):32\u20137.","journal-title":"Clin Trials Degener Dis"},{"issue":"7","key":"2778_CR201","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2217\/rme.15.49","volume":"10","author":"RF El-Demerdash","year":"2015","unstructured":"El-Demerdash RF, Hammad LN, Kamal MM, El Mesallamy HO. A comparison of Wharton\u2019s jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy. Regen Med. 2015;10(7):841\u201355.","journal-title":"Regen Med"},{"issue":"1","key":"2778_CR202","doi-asserted-by":"publisher","first-page":"30","DOI":"10.26444\/jpccr\/85329","volume":"12","author":"C Som","year":"2018","unstructured":"Som C, Venkataramana NK. Evaluation of efficacy and regenerative potential of Wharton\u2019s jelly and bone marrow derived mesenchymal stem cells in diabetic rats. J Pre-Clin Clin Res. 2018;12(1):30\u20135.","journal-title":"J Pre-Clin Clin Res"},{"key":"2778_CR203","unstructured":"Gray A, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279012\/."},{"issue":"5","key":"2778_CR204","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/nu11051022","volume":"11","author":"SN Scott","year":"2019","unstructured":"Scott SN, Anderson L, Morton JP, Wagenmakers AJM, Riddell MC. Carbohydrate restriction in type 1 diabetes: a realistic therapy for improved glycaemic control and athletic performance? Nutrients. 2019;11(5):1022.","journal-title":"Nutrients"},{"issue":"4","key":"2778_CR205","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2337\/dc10-1490","volume":"34","author":"A Laurenzi","year":"2011","unstructured":"Laurenzi A, et al. Effects of carbohydrate counting on glucose control and quality of life over 24 weeks in adult patients with type 1 diabetes on continuous subcutaneous insulin infusion: a randomized, prospective clinical trial (GIOCAR). Diabetes Care. 2011;34(4):823\u20137.","journal-title":"Diabetes Care"},{"issue":"5","key":"2778_CR206","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dci19-0014","volume":"42","author":"AB Evert","year":"2019","unstructured":"Evert AB, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019;42(5):731.","journal-title":"Diabetes Care"},{"issue":"1","key":"2778_CR207","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2337\/dc09-1327","volume":"33","author":"MC Rossi","year":"2010","unstructured":"Rossi MC, et al. Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study. Diabetes Care. 2010;33(1):109\u201315.","journal-title":"Diabetes Care"},{"issue":"5","key":"2778_CR208","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.jada.2010.03.003","volume":"110","author":"KK Kattelmann","year":"2010","unstructured":"Kattelmann KK, Conti K, Ren C. The medicine wheel nutrition intervention: a diabetes education study with the Cheyenne River Sioux Tribe. J Am Diet Assoc. 2010;110(5):S44\u201351.","journal-title":"J Am Diet Assoc"},{"issue":"10","key":"2778_CR209","doi-asserted-by":"publisher","first-page":"737","DOI":"10.7326\/0003-4819-148-10-200805200-00006","volume":"148","author":"K Cavanaugh","year":"2008","unstructured":"Cavanaugh K, et al. Association of numeracy and diabetes control. Ann Intern Med. 2008;148(10):737\u201346.","journal-title":"Ann Intern Med"},{"issue":"9","key":"2778_CR210","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1369\/jhc.5C6684.2005","volume":"53","author":"M Brissova","year":"2005","unstructured":"Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem. 2005;53(9):1087\u201397.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"2778_CR211","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1677\/JOE-08-0290","volume":"199","author":"I Quesada","year":"2008","unstructured":"Quesada I, Tudur\u00ed E, Ripoll C, Nadal A. Physiology of the pancreatic \u03b1-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol. 2008;199(1):5\u201319.","journal-title":"J Endocrinol"},{"issue":"3","key":"2778_CR212","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0940-2993(98)80078-X","volume":"50","author":"G Wieczorek","year":"1998","unstructured":"Wieczorek G, Pospischil A, Perentes E. A comparative immunohistochemical study of pancreatic islets inlaboratory animals (rats, dogs, minipigs, nonhuman primates). Exp Toxicol Pathol. 1998;50(3):151\u201372.","journal-title":"Exp Toxicol Pathol"},{"issue":"7","key":"2778_CR213","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1073\/pnas.0510790103","volume":"103","author":"O Cabrera","year":"2006","unstructured":"Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren P-O, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci. 2006;103(7):2334\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"2778_CR214","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4161\/isl.2.3.11815","volume":"2","author":"DJ Steiner","year":"2010","unstructured":"Steiner DJ, Kim A, Miller K, Hara M. Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets. 2010;2(3):135\u201345.","journal-title":"Islets"},{"issue":"1","key":"2778_CR215","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/1471-2164-15-620","volume":"15","author":"C Benner","year":"2014","unstructured":"Benner C, van der Meulen T, Cac\u00e9res E, Tigyi K, Donaldson CJ, Huising MO. The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics. 2014;15(1):620.","journal-title":"BMC Genomics"},{"key":"2778_CR216","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fendo.2018.00051","volume":"9","author":"Y-G Chen","year":"2018","unstructured":"Chen Y-G, Mathews CE, Driver JP. The role of NOD mice in type 1 diabetes research: lessons from the past and recommendations for the future. Front Endocrinol. 2018;9:51.","journal-title":"Front Endocrinol"},{"issue":"8","key":"2778_CR217","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s00125-017-4308-1","volume":"60","author":"SE Regnell","year":"2017","unstructured":"Regnell SE, Lernmark \u00c5. Early prediction of autoimmune (type 1) diabetes. Diabetologia. 2017;60(8):1370\u201381.","journal-title":"Diabetologia"},{"issue":"1","key":"2778_CR218","first-page":"1","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A, Gudbj\u00f6rnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark \u00c5. Type 1 diabetes mellitus. Nat Rev Dis Prim. 2017;3(1):1\u201317.","journal-title":"Nat Rev Dis Prim"},{"key":"2778_CR219","first-page":"2","volume":"4","author":"N Shanks","year":"2009","unstructured":"Shanks N, Greek R, Greek J. Are animal models predictive for humans? PEHM. 2009;4:2\u20132.","journal-title":"PEHM"},{"issue":"4","key":"2778_CR220","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1210\/en.2008-1224","volume":"150","author":"M Szabat","year":"2009","unstructured":"Szabat M, Luciani DS, Piret JM, Johnson JD. Maturation of adult \u03b2-cells revealed using a Pdx1\/insulin dual-reporter lentivirus. Endocrinology. 2009;150(4):1627\u201335.","journal-title":"Endocrinology"},{"issue":"8","key":"2778_CR221","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s00125-006-0308-2","volume":"49","author":"JJ Meier","year":"2006","unstructured":"Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC. Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia. 2006;49(8):1838\u201344.","journal-title":"Diabetologia"},{"issue":"2","key":"2778_CR222","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dc17-2625","volume":"42","author":"EK Sims","year":"2019","unstructured":"Sims EK, et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care. 2019;42(2):258.","journal-title":"Diabetes Care"},{"issue":"3","key":"2778_CR223","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.cmet.2017.08.013","volume":"26","author":"C Wasserfall","year":"2017","unstructured":"Wasserfall C, et al. Persistence of pancreatic insulin mRNA expression and proinsulin protein in type 1 diabetes pancreata. Cell Metab. 2017;26(3):568-575.e3.","journal-title":"Cell Metab"},{"issue":"2","key":"2778_CR224","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1110-7782.193890","volume":"28","author":"M Rehan","year":"2016","unstructured":"Rehan M. Epigenetics and diabetes mellitus. Egyp J Int Med. 2016;28(2):39\u201351.","journal-title":"Egyp J Int Med"},{"issue":"1","key":"2778_CR225","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.diabres.2010.11.006","volume":"91","author":"LL Sun","year":"2011","unstructured":"Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract. 2011;91(1):94\u2013100.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2778_CR226","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1038\/s41598-017-05787-y","volume":"7","author":"M Garcia-Contreras","year":"2017","unstructured":"Garcia-Contreras M, Shah SH, Tamayo A, Robbins PD, Golberg RB, Mendez AJ, Ricordi C. Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes. Sci Rep. 2017;7(1):5998.","journal-title":"Sci Rep"},{"issue":"10","key":"2778_CR227","first-page":"89","volume":"17","author":"ST Jerram","year":"2017","unstructured":"Jerram ST, Dang MN, Leslie RD. The role of epigenetics in type 1 diabetes. Curr DiabRep. 2017;17(10):89\u201389.","journal-title":"Curr DiabRep"},{"issue":"3","key":"2778_CR228","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.cmet.2017.01.009","volume":"25","author":"H Chakravarthy","year":"2017","unstructured":"Chakravarthy H, et al. Converting adult pancreatic islet alpha cells into beta cells by targeting Both Dnmt1 and Arx. Cell Metab. 2017;25(3):622\u201334.","journal-title":"Cell Metab"},{"issue":"5","key":"2778_CR229","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbagrm.2018.03.003","volume":"1861","author":"M Fontcuberta-PiSunyer","year":"2018","unstructured":"Fontcuberta-PiSunyer M, Cervantes S, Miquel E, Mora-Castilla S, Laurent LC, Raya A, Gomis R, Gasa R. Modulation of the endocrine transcriptional program by targeting histone modifiers of the H3K27me3 mark. Biochim Biophys Acta Gene Regul Mech. 2018;1861(5):473\u201380.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"11","key":"2778_CR230","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3390\/cells9112403","volume":"9","author":"A-SA-S Akil","year":"2020","unstructured":"Akil A-SA-S, et al. Reading between the (Genetic) lines: How epigenetics is unlocking novel therapies for type 1 diabetes. Cells 2020;9(11):2403.","journal-title":"Cells"},{"issue":"9","key":"2778_CR231","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","volume":"12","author":"RD Beger","year":"2016","unstructured":"Beger RD, et al. Metabolomics enables precision medicine: \u201cA White Paper, Community Perspective.\u201d Metabolomics. 2016;12(9):149.","journal-title":"Metabolomics"},{"issue":"2","key":"2778_CR232","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1161\/CIRCGENETICS.113.000421","volume":"7","author":"RM Cooper-Dehoff","year":"2014","unstructured":"Cooper-Dehoff RM, et al. Is diabetes mellitus-linked amino acid signature associated with beta-blocker-induced impaired fasting glucose? Circ Cardiovasc Genet. 2014;7(2):199\u2013205.","journal-title":"Circ Cardiovasc Genet"},{"issue":"6371","key":"2778_CR233","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1126\/science.aar2946","volume":"359","author":"C Jobin","year":"2018","unstructured":"Jobin C. Precision medicine using microbiota. Science. 2018;359(6371):32\u20134.","journal-title":"Science"},{"issue":"1","key":"2778_CR234","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-8587(18)30109-8","volume":"7","author":"O Bart","year":"2019","unstructured":"Bart O. Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine. Lancet Diabetes Endocrinol. 2019;7(1):65\u201374.","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-021-02778-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-021-02778-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-021-02778-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T13:36:18Z","timestamp":1698845778000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-021-02778-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2778"],"URL":"https:\/\/doi.org\/10.1186\/s12967-021-02778-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"18 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}